Tumour Necrosis Factor Alpha Antibody Affects Gastrin Release in Crohn Disease

Author： Hopman W. P. M.   Jong D. J. de   Naber A. H. J.   Jansen J. B. M. J.  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.38, Iss.5, 2003-01, pp. : 522-525

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Partial Remission of AutoImmune Thrombocytopenia in a Patient Treated with the Anti-Tumor Necrosis Factor-Alpha Antibody Infliximab for Refractory Fistulizing Crohn’s Disease

By  

Digestion, Vol. 78, Iss. 4, 2008-12 ,pp. : 195-200

Karger

Access to resources Recommend Favorite

Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-α Monoclonal Antibody Treatment for Crohn's Disease

By  

Digestion, Vol. 88, Iss. 1, 2013-06 ,pp. : 17-19

Karger

Access to resources Recommend Favorite

Tumor Necrosis Factor-Alpha in Ileal Mast Cells in Patients with Crohn’s Disease

By  

Digestion, Vol. 61, Iss. 1, 2000-02 ,pp. : 68-76

Karger

Access to resources Recommend Favorite

Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease

By  

Case Reports in Gastroenterology, Vol. 8, Iss. 1, 2014-01 ,pp. : 44-50

Karger

Access to resources Recommend Favorite

Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies

By Bendtzen Klaus   Ainsworth Mark   Steenholdt Casper   Thomsen Ole Østergaard   Brynskov Jørn  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 7, 2009-07 ,pp. : 774-781

Informa Healthcare

Access to resources Recommend Favorite